Edit profile Logout

SUPPORTING PATIENTS TO SELF-ADMINISTER NPLATE®

Amgen has developed these materials to make it as easy as possible for your patients to self-administer Nplate® and to give you
confidence that your patients are receiving their treatment as you have prescribed it.

HCP MATERIALS FOR SELF-ADMINISTRATION

BOOKLET

Selecting and training adult patients for home administration of Nplate®

Risk management plan booklet for self-administration

ITPHCPGuidesPDF
Download

CHECKLIST

Checklist for Nplate® self-administration

Risk management plan checklist
for self-administration

ITPHCPPatient managementPDF
Download

PATIENT MATERIALS FOR SELF-ADMINISTRATION

These guides have been developed for your patients with chronic ITP who are treated with Nplate® to help answer some of their questions about their condition, it’s treatment and self-administration of Nplate®. Patients can obtain a self-administration kit from their pharmacy free of charge.

PATIENT VIDEO

How to prepare and
self-administer Nplate®

Your guide to preparing and
self-administering Nplate®

ITPHCPGuidesPatient managementVideo
Watch

INFORMATION

Patient booklet

Understanding your
treatment with Nplate®

Download

References: 1. Kuter DJ et al. Am J Hematol. 2020;95:643–651. 2. Nplate® (romiplostim) Approved Product Information. www.amgen.com.au/Nplate.PI

June 2022 AU-15229

PBS Information: This product is listed on the PBS as a Section 100 item. Refer to PBS Schedule for full authority information. This product is not listed on the PBS for newly diagnosed or persistent immune thrombocytopenia.

REFER TO FULL PRODUCT INFORMATION BEFORE PRESCRIBING; AVAILABLE FROM AMGEN AUSTRALIA PTY LTD,
PH: 1800 803 638 OR AT WWW.AMGEN.COM.AU/NPLATE.PI

For more information on Nplate®, or to report an adverse event or product complaint involving Nplate®, please contact Amgen Medical Information on 1800 803 638 or

visit www.amgenmedinfo.com.au

This site is intended for Australian Healthcare Professionals only.